CA2199400A1 - Therapie photodynamique dans l'inactivation cellulaire selective dans le sang et traitement de maladies induites par une dysfonction immunitaire - Google Patents

Therapie photodynamique dans l'inactivation cellulaire selective dans le sang et traitement de maladies induites par une dysfonction immunitaire

Info

Publication number
CA2199400A1
CA2199400A1 CA002199400A CA2199400A CA2199400A1 CA 2199400 A1 CA2199400 A1 CA 2199400A1 CA 002199400 A CA002199400 A CA 002199400A CA 2199400 A CA2199400 A CA 2199400A CA 2199400 A1 CA2199400 A1 CA 2199400A1
Authority
CA
Canada
Prior art keywords
blood
photodynamic therapy
immune dysfunction
treating immune
selective cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002199400A
Other languages
English (en)
Other versions
CA2199400C (fr
Inventor
Simon Leong
Agnes How-Ching Chan
David William Carey Hunt
Martin Renke
Janice North
Julia Levy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of British Columbia
Novelion Therapeutics Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/309,509 external-priority patent/US5807881A/en
Application filed by Individual filed Critical Individual
Publication of CA2199400A1 publication Critical patent/CA2199400A1/fr
Application granted granted Critical
Publication of CA2199400C publication Critical patent/CA2199400C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002199400A 1994-09-22 1995-09-22 Therapie photodynamique dans l'inactivation cellulaire selective dans le sang et traitement de maladies induites par une dysfonction immunitaire Expired - Fee Related CA2199400C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/309,509 US5807881A (en) 1992-05-27 1994-09-22 Method for selectively reducing activated leukocyte cell population
US08/309,509 1994-09-22
PCT/CA1995/000543 WO1996009068A1 (fr) 1994-09-22 1995-09-22 Therapie photodynamique dans l'inactivation cellulaire selective dans le sang et traitement de maladies induites par une dysfonction immunitaire

Publications (2)

Publication Number Publication Date
CA2199400A1 true CA2199400A1 (fr) 1996-03-28
CA2199400C CA2199400C (fr) 2006-02-14

Family

ID=35892305

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002199400A Expired - Fee Related CA2199400C (fr) 1994-09-22 1995-09-22 Therapie photodynamique dans l'inactivation cellulaire selective dans le sang et traitement de maladies induites par une dysfonction immunitaire

Country Status (1)

Country Link
CA (1) CA2199400C (fr)

Also Published As

Publication number Publication date
CA2199400C (fr) 2006-02-14

Similar Documents

Publication Publication Date Title
BR9509205A (pt) Terapia fotodinâmica em inativação seletiva de célula em sangue e tratamento de doenças de disfunção imune
GEP20002146B (en) Therapeutic Peptide Derivatives
EP0333606A3 (en) Preparation of t-cell and t-cell membrane for use in prevention and treatment of autoimmune diseases
MY113059A (en) Controlled-release dosage forms of azithromycin
MY111196A (en) Therapeutic aplication of chimeric and radiolabeled antibodies to human b lymphocyte restricted differentiation antigen for treatment of b cell lymphoma
CA2149924A1 (fr) Utilisation de la phenserine pour traiter les troubles cognitifs
PL338982A1 (en) Drug for improving duration of muscle action or for treating muscular disorders or diseases
AU693833B2 (en) Products containing G-CSF and TNF binding protein
IL133913A (en) Treatment of inflammatory disorders of the bowel and urinary bladder
CA2199400A1 (fr) Therapie photodynamique dans l'inactivation cellulaire selective dans le sang et traitement de maladies induites par une dysfonction immunitaire
RU95109332A (ru) Способ лечения больных хроническими заболеваниями печени с проявлениями печеночной недостаточности путем плазмафереза
AU6955396A (en) Combination therapy for advanced cancer comprising temozolomide and cisplatin
RU95105085A (ru) Способ воздействия на биологический объект
AU7373196A (en) Combination of temozolomide and alpha-ifn for the treatment of advanced cancer
RU93032381A (ru) Способ лечения хронического описторхоза
RU94045661A (ru) Способ очищения организма
UA10928C2 (uk) Спосіб профілактики гіперхолестериhемії
RU94020373A (ru) Способ лечения больных ревматоидным артритом
UA30125A (uk) Спосіб лікування дітей з ревматоїдним артритом та дифузними хворобами сполучної тканини
WO1993022433A3 (fr) Medicament permettant de traiter l'homme, les animaux et les plantes par therapie genetique, dans le but notamment de bloquer la proliferation de virus et les carcinogenes et procede de fabrication dudit medicament
MX9603833A (es) Tratamiento mejorado del cancer con temozolomida.
RU95106897A (ru) Способ лечения разных форм псориаза
葛通远 et al. AN APPROACH TO THE MECHANISMS OF LASER ACUPUNCTURE IN TREATMENT OF EXOPHTHALMIC HYPERTHYROIDISM
GEP19981480B (en) Method for Treating Vertebral Column
RU93033709A (ru) Способ обработки крови

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed